— Know what they know.
Not Investment Advice

MPLT NASDAQ

MapLight Therapeutics, Inc.
1W: -0.0% 1M: -8.9% 3M: +63.8% YTD: +74.6%
$28.75
-0.53 (-1.81%)
 
Weekly Expected Move ±13.4%
$21 $25 $29 $33 $36
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 38 · $22.7M mcap · 300289 float · 87.81% daily turnover · Short 87% of daily vol

Cash Flow Trends

Operating Cash Flow
-$138M -75.3% ▼
Capital Expenditures
$473K +38.6% ▲
3Y CAGR: -14.1%
Free Cash Flow
-$139M -74.2% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$8M +120.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$30M-$56M-$78M-$161M
Depreciation & Amort.$574K$556K$701K$578K
Stock-Based Comp.$0$0$0$0
Change in Working Capital$2M$2M-$3M-$13M
Other Non-Cash Items$1M$1M$1M$35M
Operating Cash Flow-$27M-$52M-$79M-$138M
— Investing Activities —
Capital Expenditures-$746K-$462K-$770K-$473K
Acquisitions (Net)$0$0$0$0
Investment Purchases$0$0-$125M-$408M
Investment Sales$0$0$45M$86M
Other Investing$0$0$0$0
Investing Cash Flow-$746K-$462K-$81M-$323M
— Financing Activities —
Net Debt Issuance$0$0$0$0
Stock Repurchased$0$0$0$0
Dividends Paid$0$0$0$0
Other Financing$0$0-$2M-$5M
Financing Cash Flow$33M$105M$118M$470M
Net Change in Cash$28M$52M-$42M$8M
Cash End of Period$28M$80M$38M$47M
Free Cash Flow-$27M-$52M-$80M-$139M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms